Michael Schultz Selected Research

Michael Schultz Research Topics

Disease

13	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2020 - 01/2003
8	Ulcerative Colitis 10/2015 - 01/2003
7	Neoplasms (Cancer) 01/2019 - 05/2004
7	Crohn Disease (Crohn's Disease) 01/2019 - 01/2003
6	Pain (Aches) 03/2022 - 05/2004
5	Colitis 09/2015 - 03/2002
4	Hemorrhage 05/2022 - 10/2012
4	Hepatitis C 11/2020 - 08/2008
3	Infections 01/2020 - 05/2013
3	Fatigue 04/2019 - 10/2010
3	Melena 01/2019 - 12/2017
3	Inflammation (Inflammations) 12/2013 - 03/2002
2	Hematemesis 01/2019 - 01/2018
2	Vomiting 01/2018 - 12/2017
2	Body Remains 07/2017 - 01/2004
2	Breast Neoplasms (Breast Cancer) 03/2015 - 05/2004
1	Peptic Ulcer (Peptic Ulcers) 05/2022
1	Hypertension (High Blood Pressure) 03/2022
1	Pruritus (Itching) 03/2022
1	Calculi (Calculus) 12/2021
1	Celiac Disease (Celiac Sprue) 01/2021
1	Stroke (Strokes) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 10/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Necrosis 01/2019
1	Non-alcoholic Fatty Liver Disease 04/2018
1	Varicose Veins (Varicose Vein) 01/2018
1	Epilepsy (Aura) 01/2018
1	Heart Failure 11/2017
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 07/2017
1	Chronic Disease (Chronic Diseases) 01/2017
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2017
1	Astigmatism 01/2016
1	Cataract (Cataracts) 01/2016
1	Phimosis 01/2016
1	Procedural Pain 03/2015
1	Intestinal Diseases (Diseases, Intestinal) 06/2014
1	Chronic Hepatitis C 05/2013
1	Headache (Headaches) 05/2013

Drug/Important Bio-Agent (IBA)

4	AntigensIBA 12/2013 - 03/2004
3	Coffee FDA Link 01/2019 - 12/2017
3	Mesalamine (Mesalazine)FDA LinkGeneric 10/2011 - 03/2004
3	Anti-Bacterial Agents (Antibiotics)IBA 02/2011 - 01/2003
2	Ribavirin (Virazole)FDA LinkGeneric 11/2020 - 05/2013
2	SofosbuvirIBA 11/2020 - 05/2013
2	Antiviral Agents (Antivirals)IBA 11/2020 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 04/2019 - 12/2007
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2019
2	Hemoglobins (Hemoglobin)IBA 01/2019 - 01/2018
2	2-mercaptopurineIBA 01/2019 - 05/2018
2	Adalimumab (Humira)FDA Link 01/2019 - 06/2014
2	17-hydroxyestrane-3-carbonitrile (ECN)IBA 06/2005 - 03/2004
1	Amlodipine (Norvasc)FDA LinkGeneric 03/2022
1	SmokeIBA 12/2021
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2021
1	Antidepressive Agents (Antidepressants)IBA 01/2021
1	Serotonin (5 Hydroxytryptamine)IBA 01/2021
1	daclatasvirIBA 11/2020
1	sofosbuvir drug combination ledipasvirIBA 11/2020
1	glecaprevir and pibrentasvirIBA 01/2020
1	EnzymesIBA 01/2019
1	Monensin (Coban)IBA 01/2019
1	A-factor (Streptomyces)IBA 01/2019
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2019
1	Infliximab (Remicade)FDA Link 01/2019
1	AntibodiesIBA 01/2019
1	ImmunosorbentsIBA 01/2019
1	FructoseIBA 04/2018
1	Glucose (Dextrose)FDA LinkGeneric 04/2018
1	Hemostatics (Antihemorrhagics)IBA 01/2018
1	OligosaccharidesIBA 07/2017
1	DisaccharidesIBA 07/2017
1	polyolIBA 07/2017
1	Ga(III)-DOTATOCIBA 01/2017
1	Capsules (Microcapsules)IBA 01/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2015
1	Interleukin-12 Subunit p40IBA 09/2015
1	Eosine Yellowish-(YS) (Eosin)IBA 09/2015
1	Interleukin-10 (Interleukin 10)IBA 09/2015
1	Interleukin-4 (Interleukin 4)IBA 09/2015
1	Interleukin-2 (IL2)IBA 09/2015
1	Interleukin-6 (Interleukin 6)IBA 09/2015
1	AG 85IBA 06/2015
1	Meperidine (Pethidine)FDA LinkGeneric 03/2015
1	Vitamin D FDA LinkGeneric 05/2014
1	Immunologic Factors (Immunomodulators)IBA 12/2013
1	Biological ProductsIBA 12/2013
1	peginterferon alfa-2a (Pegasys)FDA Link 05/2013
1	NucleotidesIBA 05/2013

Therapy/Procedure

11	Therapeutics 05/2022 - 03/2002
3	Length of Stay 01/2021 - 11/2017
2	Intraocular Lenses (Intraocular Lens) 01/2016 - 01/2016
2	Analgesia 03/2015 - 08/2008
1	Ostomy 10/2020
1	Ambulatory Care (Outpatient Care) 01/2020
1	Aftercare (After-Treatment) 01/2020
1	Vagus Nerve Stimulation 01/2018
1	Trephining 07/2017
1	Lasers (Laser) 01/2016
1	Adjuvant Chemotherapy 03/2015